Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study

OBJECTIVE: Analysis of etanercept biosimilars in pediatric patients with juvenile idiopathic arthritis (JIA) in comparison with the etanercept originator in terms of efficacy and safety. METHODS: Patients diagnosed with JIA who started treatment with either the etanercept originator or a biosimilar...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiele, Franz, Klein, Ariane, Hospach, Anton, Windschall, Daniel, Mrusek, Sonja, Ruehlmann, J. Michael, Horneff, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593791/
https://www.ncbi.nlm.nih.gov/pubmed/34449981
http://dx.doi.org/10.1002/acr2.11325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593791/
https://www.ncbi.nlm.nih.gov/pubmed/34449981
http://dx.doi.org/10.1002/acr2.11325

Ejemplares similares